CCA Industries settles Mega-T class action
This article was originally published in The Tan Sheet
Executive Summary
CCA Industries pays $2.5 million to resolve a class action lawsuit alleging misleading advertising on the packaging of Mega-T supplement products. The East Rutherford, N.J.-based manufacturer May 28 said the settlement of the suit is subject to approved by the Superior Court of Los Angeles and includes a one-time payment of $2.5 million by CCA to those that purchased the product. The company denies allegations of any wrongdoing and liability in regard to its advertising, CCA President Dunnan Edell said in a release. The firm also agreed to change packaging for the Mega-T products in question
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.